← All indications
Cytomegalovirus Infections
Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
Subtype terms (1)
More specific conditions that are subtypes of Cytomegalovirus Infections in the MeSH hierarchy.
- Cytomegalovirus Retinitis
14 drugs (13 approved, 1 experimental)
Drugs by status
Approved for this indication (6)
Phase 4 trials (16)
Phase 3 trials (17)
Phase 2 trials (32)
- autologous ebv specific cytotoxic t lymphocytes
- autologous t cells
- csj148
- fiacitabine
- aldesleukin
- mcmv3068a
- mcmv5322a
- sevirumab
- temozolomide
- desflurane
- v160
- vcp260
- autologous cmv-specific ctl
- cmv gb vaccine
- human placental derived stem cells
- ifnγ- positive selected t-cells
- hb-101
- multi-peptide cmv-modified vaccinia ankara vaccine
- autologous mesenchymal stem cells
- cytotoxic t cells
- misoprostol
- cytomegalovirus-specific t-cells
- adenovirus-specific t-cells
- estrogen
- t lymphocytes
- cmv-mva
- virus-specific T cells
- cmv/adv /ebv/bkv specific t cells
- npc-21
- ebv-tcr-t cells
- +2 more
Phase 1 trials (24)
- didanosine
- procaine benzylpenicillin
- gsk1492903a
- filociclovir
- tcn-202
- tetanus-cmv fusion peptide vaccine
- digoxin
- vbi-1501
- avx601
- cmv/adv specific t cells
- allogeneic multivirus - directed cytotoxic t lymphocytes
- cymvectin
- multivirus specific t cells
- multi-virus-specific cytotoxic t lymphocytes
- vcl-cb01
- Posoleucel
- zidovudine
- dextromethorphan
- bd03
- mrna-1443
- r-mvst
- cmv pp65 peptide-loaded alpha-type-1 polarized dendritic cell vaccine
- immunecellvir
- SPYVLP01
Organizations
Organization Involved with Phase 4 Indications (29)
- CSL Behring
- ViiV Healthcare
- Astra
- Novartis
- Fundação Pró Rim
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Associação Médico Espírita de Botucatu
- University of Pittsburgh
- University of London
- Harvard University
- Hospital do Rim e Hipertensão
- Hospital Geral de Fortaleza
- Lower Saxony Center for Nephrology
- Singapore Eye Research Institute
- Singapore National Eye Centre
- Stanford University
- University of Oslo
- University of South Carolina
- University of Bordeaux
- University of Zurich
- University of California, San Francisco
- Jiao Tong University
- Janssen Pharmaceutica NV
- University of Barcelona
- University of Paris
- University of New South Wales
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
- UNITAID
Organization Involved with Phase 3 Indications (42)
- BioAnaLab
- ViroPharma
- Shire
- Chimerix
- Glaxo Wellcome
- CMV Research Foundation
- PENTA Foundation
- National Cancer Institute (NCI)
- National Center for Research Resources (NCRR)
- National Heart, Lung, and Blood Institute (NHLBI)
- Brown University
- Duke University
- University of Washington
- Institut National de la Santé Et de la Recherche Médicale, France
- Katholieke Universiteit Leuven
- Makerere University
- Universidad Complutense de Madrid
- University of Pavia
- University of Bologna
- Virginia Commonwealth University
- University of Zimbabwe
- Tel Aviv University
- Leiden University
- Hebrew University
- Kuur Therapeutics
- University of North Carolina at Chapel Hill
- Universidade Eduardo Mondlane
- Wellcome Trust
- Washington University in St. Louis
- George Washington University
- +12 more
Organization Involved with Phase 2 Indications (39)
- Oclassen
- Genentech
- Sanofi-Aventis
- Atara Biotherapeutics
- Moderna Therapeutics
- Nobel Pharmaceuticals
- PETHEMA Foundation
- Samsung Medical Center
- University of Pennsylvania
- Cornell University
- Medical College of Wisconsin
- New York Medical College
- Shenzhen Geno-Immune Medical Institute
- St. Anna Kinderkrebsforschung
- Universidad Autonoma de Madrid
- University of Bern
- University of Birmingham
- Fudan University
- Peking University
- Icahn School of Medicine at Mount Sinai
- University of Vienna
- University of Minnesota
- Southern Medical University
- Medical University of Vienna
- Fortress Biotech
- Sun Yat-Sen University
- City of Hope National Medical Center
- University of Texas at Houston
- Pennsylvania State University
- University of Alabama, Birmingham
- +9 more
Organization Involved with Phase 1 Indications (20)
- Sandoz
- Astellas
- GlaxoSmithKline
- Hookipa Biotech
- Theraclone Sciences, Inc.
- VBI Vaccines Inc.
- Vical
- ViraCyte
- AlphaVax, Inc.
- Baylor University
- Case Western Reserve University
- Dalhousie University
- Universitair Ziekenhuis Gent
- Methodist Cancer Center, Houston, Texas
- Shin Nippon Biomedical Laboratories
- University of Wisconsin
- Clinical Trial Data Services, LLC
- China Immunotech
- SL BIGEN
- Ludaopei Hospital
Organization Involved with Other Experimental Indications (9)